Agilent Technologies, Inc.
NYSE-A
Company Overview
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Name
Agilent Technologies, Inc.
CEO
Mr. Padraig McDonnell
Website
www.agilent.com
Sector
Life Sciences Tools and Services
Year Founded
1999
Profile
Market Cap
$39.45B
EV
$40.79B
Shares Out
287.33M
Revenue
$6,497M
Employees
17,400
Margins
Gross
54.39%
EBITDA
24.07%
Operating
20.22%
Pre-Tax
23.7%
Net
21.75%
FCF
21.81%
Returns (5Yr Avg)
ROA
10.71%
ROTA
24.94%
ROE
20.99%
ROCE
16.06%
ROIC
15.32%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$147.51
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$1,779M
Net Debt
$1,337M
Debt/Equity
0.53
EBIT/Interest
15.28
Growth (CAGR)
Rev 3Yr
1.89%
Rev 5Yr
5%
Rev 10Yr
3.24%
Dil EPS 3Yr
14.48%
Dil EPS 5Yr
7.57%
Dil EPS 10Yr
8.89%
Rev Fwd 2Yr
-0.21%
EBITDA Fwd 2Yr
2.75%
EPS Fwd 2Yr
2.13%
EPS LT Growth Est
6.11%
Dividends
Yield
—
Payout
19.26%
DPS
$0.93
DPS Growth 3Yr
6.98%
DPS Growth 5Yr
7.8%
DPS Growth 10Yr
6.1%
DPS Growth Fwd 2Yr
6.76%